MELOSO BAR - AN OVERVIEW

The introduction of nicotinamide as being a nicotine substitution in e-cigarette and smokeless merchandise represents a big regulatory challenge to the FDA. Nicotinamide does not have nicotinic receptor agonist activity and is understood to act as a sedative at substantial dosages6. The claims made by Nicotine River, ECBlend, and various distributo